Good reasons for LTS

The path from the developed substance to the successful transdermal therapeutic system (TTS) or oral thin film (OTF) is a long and labour-intensive one. As such, you need a strong, experienced and commited partner at your side. LTS as the market leader fulfils all these requirements.

  • LTS leads the way globally in transdermal therapeutic systems LTS TTS and oral thin films LTS OTF.

  • With its partners from the pharmaceutical industry, LTS has developed the most TTS products onto the market. These transdermal patches make treatment much easier for a large number of patients.

  • LTS has the experience and expertise to develop and manufacture successful products right up to market approval.

  • LTS has sufficient capacity to manufacture the batch sizes required for global sales and high-volume products. Two identical production facilities in Andernach (Germany) and West Caldwell (USA) secure supply chain reliability even in crisis periods.

  • LTS has production capabilities of varying sizes to operate all demands from early drug development to large-scale production campaigns. As such, LTS matches its manufacturing processes for its products customer specific to the ideal equipment.

  • LTS is recognised by all major health authorities the world over.

  • LTS has broad experience in the field of hormone therapy and with anaesthetics narcotic substances.

  • LTS systematically separates the production of hormone products from non-hormone products avoiding any risk of possible cross – contamination.

  • LTS offers all services from a single source – from feasibility studies and clinical trials (up to phase II) to production and packaging.
    For more information, visit the CRS-Website!

  • LTS supports each client with its very own development team, which can also be integrated into a client´s research team comprising employees from the client company.

  • On the basis of mutual trust, LTS offers its customers complete transparency in all project phases.

LTS is a global leader in transdermal therapeutic systems and oral drug films. And there are more good reasons to have LTS as a partner.